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Abstract: Infections with Cronobacter sakazakii are mainly
described among neonates and infants, with contaminated powdered
infant formulas most often incriminated as the cause. We describe
here a case of C. sakazakii bacteremia secondary to a suspected cyst
infection in a heart-and-kidney transplant patient with polycystic
kidney disease.
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Previously known as a “yellow-pigmented” variant of
Enterobacter cloacae (1), Cronobacter sakazakii is a well-
known pathogen related to foodborne disease. Con-
sumption of powdered infant formulas contaminated
with C. sakazakii is classically related to infections
among neonates and infants (2). Clinical presentations
consist of sepsis, meningitis, and necrotizing entero-
colitis (3). Serious complications of C. sakazakii menin-
gitis are cyst formation, cerebral abscesses, infarction,
hydrocephalus, or quadriplegia (4). Mortality rate can
rise up to 41.9% for neonates with meningitis, 19% for
necrotizing enterocolitis, and 10% for bacteremia (5).
For C. sakazakii infections among infants, risk factors
such as low birth weight, premature birth, immuno-
compromised status, infants from human immunodefi-
ciency virus-positive mothers, and neonates in intensive
care unit have been suggested (1, 3).
Only a few cases of C. sakazakii infections among
adults have been reported in the literature (Table 1) (2,
4, 6–13). Mainly immunocompromised adults at an
advanced age (>55 years) and with underlying disease,
such as solid organmalignancies, were implicated (2–4).
Various clinical presentations were seen in these adult
patients, such as bacteremia (2), pneumonia (6), chole-
cystitis (2), or urinary tract infection (7). Only 2 cases
affecting immunocompetent patients without underlying
disease have been reported: one with postsurgical
osteomyelitis (8), and a second one with multiple splenic
abscesses caused by C. sakazakii (9). To the best of our
knowledge, we describe here the first case of bacteremia
secondary to cyst infection with C. sakazakii in a patient
with polycystic kidney disease (PKD), who was on
maintenance immunosuppressive medication after a
combined heart-and-kidney transplantation.
Case report
A 53-year-old man with a history of autosomal dom-
inant polycystic kidney disease (ADPKD) and dilated
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cardiomyopathy, for which he underwent a combined
kidney and heart transplantation in February 2010,
was admitted to the emergency department in
November 2014. Before his transplantation in the
right lower quadrant, the patient had undergone a
right nephrectomy in January 2009. His daily medica-
Cronobacter sakazakii infections in adults
Author
(reference)
Age yrs/
gender
Isolation
site Clinical presentation Underlying condition Treatment Outcome
Tsai et al. (2) 77/M Blood Cardiac arrest at
arrival at emergency
Laryngeal cancer,
diabetes mellitus,
pulmonary
tuberculosis
NA Died
72/M Blood Fever Gastric carcinoma NA Recovered
37/M Bile Abdominal pain, acute
cholecystitis
NA NA Recovered
64/F Sputum Hemoptysis, pneumonia Breast carcinoma NA Recovered
Lai (4) 39/M Sputum Aspiration pneumonia Metastatic tonsillar
carcinoma
Ceftazidime and clindamycin (5 d)
followed by cefuroxime axetil and
clindamycin (2 d)
Recovered
73/F Bile,
blood
Biliary sepsis (painless
jaundice)
Klatskin tumor of the
common bile duct
Piperacillin-tazobactam (3 d) and
1 dose of gentamicin followed by
imipenem (1 d)
Died
82/F Blood Abdominal aortic
aneurysm
NA Ofloxacin (1 d) followed by
ofloxacin and piperacillin/
tazobactam (5 d)
Died
76/F Sputum Unresponsiveness and
pneumonia
Cecal volvulus Tobramycin and ceftazidim (2 d)
followed by tobramycin and
ofloxacin (7 d), ofloxacin (1 d)
Died
Gosney et al. (6) –/– Mouth Aspiration pneumonia Stroke patient NA NA
Bhat et al. (7) 63/F Urine Urinary tract infection Chronic renal failure NA Died
Corti et al. (8) 22/M Biopsy Postsurgical
osteomyelitis of the
femur
None Levofloxacin IV (13 d) and
gentamicin/vancomycin
impregnated beads (10 d),
followed by PO levofloxacin (6 w)
Recovered
See et al. (9) 75/M Blood Multiple splenic
abscesses
None Ceftriaxone and metronidazole,
followed by imipenem
Recovered
Emery &
Weymouth
(10)
68/M Blood,
urine
Bacteremia, UTI CLL, ethanol abuse Ceftriaxone (5 doses),
gentamicin (3 doses)
Died
Hawkins
et al. (11)
75/F Blood Bacteremia Hypertension, chronic
atrial fibrillation, CVA
Cefuroxime (1 d), followed by
ceftriaxone (7 d) and
ciprofloxacin (7 d)
Recovered
Jimenez &
Gimenez (12)
76/M Blood,
urine
Bacteremia, UTI Rectal adenocarcinoma Ampicillin + gentamicin (NA) Recovered
Pribyl
et al. (13)
56/M Bone
biopsy
Osteomyelitis of the
foot
Diabetes mellitus Aztreonam (22 d) Recovered
Tamigniau
et al. (PR)
53/M Blood Fever and muscle
pain
ADPKD, kidney and
heart transplant
patient
Piperacillin/tazobactam (1 d)
followed by IV levofloxacin
(4 d) and PO levofloxacin (9 d)
Recovered
yrs, years; M, male; NA, not available; F, female; d, day(s); IV, intravenous; PO, per os/oral; w, weeks; UTI, urinary tract infection; CLL, chronic
lymphocytic leukemia; CVA, cerebrovascular accident; PR, present report; ADPKD, autosomal dominant polycystic kidney disease.
Table 1
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tions consisted of nebivolol, pravastatin, and tacroli-
mus.
On admission, the patient presented with fever
(38.6°C) and muscle pain. Some weeks earlier, his
general practitioner had started a 10-day therapy with
amoxicillin-clavulanic acid for pain in his left flank and a
blood analysis pointing at inflammation/infection with
an increased level of C-reactive protein (CRP). The
patient did not receive any antimicrobial prophylactic
treatment in the period preceding the onset of symp-
toms. No obvious symptoms pointed to a focus of the
current infection.
Blood pressure was 119/70 mmHg with a pulse rate
of 107 beats/min and an O2 saturation of 98%. No
significant abnormalities were shown on electrocardio-
gram, and clinical examination revealed only a mild
percussion pain over his native left kidney. Chest
radiography was unremarkable, while abdominal ultra-
sound examination revealed the presence of multiple
cysts in the liver and in the left kidney, compatible with
ADPKD with liver involvement.
Blood analysis revealed signs of inflammation, with a
CRP level at admission of 16.3 mg/L (normal ≤5 mg/
L). White blood cell count was within reference ranges,
but with a left shift with 92.5% of neutrophils. Urine
chemistry was normal and urine culture was negative.
Two sets of blood cultures were drawn at admission
and both sets were flagged positive after 12 h of
incubation in BacTalert 3D (Biomerieux, Marcy
l’Etoile, France). Gram staining of the culture showed
gram-negative bacilli. Subculture on a blood and a
MacConkey agar plate revealed growth after 24 h of
incubation at 37°C. Identification was carried out with
matrix-assisted laser desorption ionization–time of
flight mass spectrometry (MALDITOF) (Microflex
LT, Bruker Daltonik, Bremen, Germany), and suscep-
tibility testing was performed with Vitek 2
(Biomerieux). C. sakazakii was identified by means of
MALDITOF and confirmed successfully by 16S rRNA
gene sequencing. The strain had an overall high
antimicrobial susceptibility pattern with resistance only
to cefuroxime.
Piperacillin-tazobactam was started empirically
before blood cultures became positive with gram-
negative bacilli. Despite a good initial response to this
antimicrobial therapy, CRP kept rising, reaching up to
252.2 mg/L on day 2 of admission, and the patient
remained febrile. Based on the strain’s susceptibility
results, the patient was switched to intravenous
levofloxacin (500 mg/day), which was chosen for its
good penetration properties into cysts. A favorable
evolution was rapidly noted with normalization of the
inflammatory parameters.
The patient could be discharged after 1 week, with
continued antibiotic therapy for up to 14 days after the
C. sakazakii bacteremia episode. A week after dis-
charge, a definite favorable clinical and biochemical
evolution was documented during a follow-up outpa-
tient visit.
Discussion
We report an immunocompromised patient with PKD
presenting with C. sakazakii bacteremia secondary to a
suspected cyst infection. In ADPKD patients, the risk of
cyst infection is low with an estimated incidence around
0.01 episode/patient/year (14). Causative microorgan-
isms are mainly Enterobacteriaceae and rarely staphy-
lococci or streptococci (15).
Establishing the diagnosis of cyst infection in
ADPKD patients remains a true challenge. Indeed,
medical imaging is of little help because of its poor
diagnostic performance, especially when it comes to
differentiation between infectious versus hemorrhagic
processes. Failure rates for diagnosis of cyst infection
can be as high as 94% for ultrasonography, 82% for
computed tomography, and 60% for magnetic reso-
nance imaging (14–17). In some patients, the diagnosis
can only be established through needle aspiration or
fine-needle biopsy (16). Evidence of neutrophil debris
and/or positive cyst fluid culture can confirm the
diagnosis of cyst infection, but those techniques remain
difficult and risky (14).
Infected renal cysts are often not only difficult to
localize with conventional imaging techniques, but they
can also be difficult or impossible to access with an
ultrasound-guided procedure owing to the cysts’ loca-
tion (14, 18, 19). Therefore, needle aspiration or biopsy
is mainly restricted to hepatic cysts that are larger and
easier to access (18). Also, needle aspiration for
diagnostic purposes is performed in case of therapeutic
failure following prolonged antibiotic treatment.
In our patient, urine culture was negative, which
could seem somewhat uncommon for a renal cyst
infection. However, in ADPKD patients, renal cysts
may be disconnected from the parent nephron and
thus not show any connection with the rest of the
urinary tract, hence without bacteriuria or positive
urine culture in case of cyst infection (15, 20). In their
retrospective study, Sallee et al. (14) found a positive
urine culture in only 16 of the 31 patients with likely
and definite renal cyst infections. Pirson and Kanaan
(18) associated a positive urine culture and response
to antimicrobial therapy within 48–72 h with a likely
pyelonephritis, while renal cyst infection is, in most
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cases, associated with temperature (>38°C), pain
localized around the kidney, negative urine culture,
and positive blood culture in >50% of cases. In our
patient, the diagnosis was based on the combination of
the clinical presentation, laboratory findings, imaging
studies, and the patient’s history. With these consid-
erations in mind, the hypothesis of a likely cyst
infection as the focus for the C. sakazakii bacteremia
was very compelling.
Considering the treatment of cyst infections in
ADPKD patients, several studies have been published
regarding the cyst penetration by antimicrobial agents.
It is well acknowledged that penicillins and cephalo-
sporins exhibit a relatively poor penetration into cysts
and therapeutic concentrations can only be achieved
after several days of treatment (15, 21, 22). On the
other hand, fluoroquinolones, such as levofloxacin,
exhibit lipophilic properties ensuring better cyst pene-
tration (14, 23). For larger cysts (diameter >5 cm) –
and in particular liver cysts – surgical drainage should
be considered because of the poor outcome associated
with antimicrobial therapy alone (14). In our patient,
the biggest cysts had a diameter of 4.2 cm in the liver,
and 4.0 cm in the kidney. The clinicians chose to treat
the cyst infection with antimicrobial therapy without a
surgical procedure.
The C. sakazakii isolated from the presented case
was highly susceptible, as has been reported in
literature data (1, 8, 24, 25). The isolate was only
resistant to cefuroxime. Likewise, Stock and Wiede-
mann (26) showed that C. sakazakii isolates did not
produce any intrinsic beta-lactamases nor did they
harbor resistance to cephalosporins. Nevertheless,
resistance to cephamycins (e.g., cephalothin) has been
described that is associated with the presence of AmpC
beta-lactamases type CSA-1 and CSA-2 in C. sakazakii
isolates (25, 27).
This emergence of resistance mechanisms in food-
borne pathogens has been associated with factors such
as environmental stresses encountered during the
processing of food. The group of Al-Nabulsi et al. (28)
tested the effect of various stresses (desiccation, heat,
cold, etc.) and showed a significant change in the
susceptibility pattern of C. sakazakii isolates. Among
the cases from our literature review, the strains
described in Lai’s study (4) were strikingly more
resistant, compared with other strains described in
the literature, with resistance to ampicillin, cefazolin,
and extended-spectrum penicillins, and with variable
susceptibility to third-generation cephalosporins and
quinolones. Lai hypothesized that this increasing trend
of resistance was potentially related to selective antibi-
otic pressure in a large hospital.
Conclusions
We report an adult case of C. sakazakii bacteremia
secondary to a suspected cyst infection in a kidney-and-
heart transplant patient with PKD. So far, C. sakazakii
has been mainly described as a cause of neonatal and
pediatric infections, and only a dozen adult cases have
been reported in literature.
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